Devices & Diagnostics Letter

Oct. 8, 2012 | Vol. 39 No. 40

DoJ Lawyer: Research May Be Next Frontier in Anti-Fraud Investigations

BOSTON — Anti-fraud investigators may soon be taking a closer look at device clinical trials in an attempt to ensure that the safety and performance of devices reaching the market are supported by sound data, a government lawyer says.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

OIG Issues Fraud Alert on Kickbacks By Doctor-Owned Distributorships Healthcare Fraud Recoveries Climb, Aided by Rash of DME Convictions FDA: Public Will Maintain Access to Misconduct Investigation Data FDA on Right Track for MDRs But Still Has a Ways to Go: OIG

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.